Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder.
Paschen-Wolff M, Greenfield SF, Kathryn McHugh R, Burlew K, Pavlicova M, Choo TH, Barbosa-Leiker C, Ruglass LM, Mennenga S, Rotrosen J, Nunes EV, Campbell ANC. Paschen-Wolff M, et al. Among authors: burlew k. Am J Addict. 2023 Nov;32(6):584-592. doi: 10.1111/ajad.13463. Epub 2023 Aug 15. Am J Addict. 2023. PMID: 37583120 Clinical Trial.
Editorial: Special issue on racism, racial identity, and substance use.
Montgomery L, Burlew K, McCuistian C. Montgomery L, et al. Among authors: burlew k. J Subst Use Addict Treat. 2023 Oct;153:209132. doi: 10.1016/j.josat.2023.209132. Epub 2023 Aug 7. J Subst Use Addict Treat. 2023. PMID: 37558182 No abstract available.
Advancing Health Equity through Substance Use Research.
McCuistian C, Burlew K, Espinosa A, Ruglass LM, Sorrell T. McCuistian C, et al. Among authors: burlew k. J Psychoactive Drugs. 2021 Nov-Dec;53(5):379-383. doi: 10.1080/02791072.2021.1994673. Epub 2021 Oct 28. J Psychoactive Drugs. 2021. PMID: 34706637 Free PMC article.
Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone.
Ruglass LM, Scodes J, Pavlicova M, Campbell ANC, Fitzpatrick S, Barbosa-Leiker C, Burlew K, Greenfield SF, Rotrosen J, Nunes EV Jr. Ruglass LM, et al. Among authors: burlew k. Drug Alcohol Depend. 2019 Dec 1;205:107649. doi: 10.1016/j.drugalcdep.2019.107649. Epub 2019 Oct 21. Drug Alcohol Depend. 2019. PMID: 31704382 Free PMC article. Clinical Trial.
13 results